You just read:

Viracta Announces Oral Presentation on Lead Program for EBV-associated Lymphomas at the 2019 American Society of Hematology (ASH) Annual Meeting

News provided by

Viracta Therapeutics, Inc.

Nov 06, 2019, 09:15 ET